Parkinson's Disease Clinical Trial
Official title:
A Randomized Controlled Feasibility Trial to Determine the Effectiveness of Set Dancing for People With Parkinson's Disease
Verified date | August 2013 |
Source | University of Limerick |
Contact | n/a |
Is FDA regulated | No |
Health authority | Ireland: University of Limerick |
Study type | Interventional |
The aim of this study is to investigate if set dancing is beneficial and feasible for those
with Parkinson's disease in Ireland. The hypothesis of this feasibility study are that:
- Participants will be able to partake fully in the intervention without reporting
adverse events.
- There will be evidence of gains in functional exercise tolerance, balance, motor
performance and quality of life in those with Parkinson's disease who participate in
eight weeks of set dancing classes compared to a control group.
Status | Completed |
Enrollment | 24 |
Est. completion date | August 2013 |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Have a diagnosis of idiopathic Parkinson's disease (Hackney et al 2007; Marchant et al 2010), stage 1-2.5 on the Hoeln and Yahr scale for staging of Parkinson's disease (Batson 2010) - Showing a clear benefit from anti-Parkinson medication (Marchant et al 2010) - Able to walk three meters with or without an assistive device (Hackney and Earhart 2009) - Not pregnant - Over 18 year of age - Have a TV and DVD player in their own home to allow them to participate in the home exercise programme. Exclusion Criteria: - A serious cardiovascular and/or pulmonary condition (Lodder et al 2004) - A neurological deficit other than Parkinson's disease (Batson 2010; Marchant et al 2010) - Evidence of a musculoskeletal problem contraindicating participation in exercise participation(Duncan and Earhart 2012) - A cognitive or hearing problem which will effect their ability to follow instructions or hear the music (Batson 2010) - Participated in regular dance classes in the past six months (Marchant et al 2010) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Ireland | University of Limerick | Limerick | Munster |
Lead Sponsor | Collaborator |
---|---|
University of Limerick |
Ireland,
Hackney ME, Earhart GM. Effects of dance on gait and balance in Parkinson's disease: a comparison of partnered and nonpartnered dance movement. Neurorehabil Neural Repair. 2010 May;24(4):384-92. doi: 10.1177/1545968309353329. Epub 2009 Dec 14. — View Citation
Hackney ME, Kantorovich S, Levin R, Earhart GM. Effects of tango on functional mobility in Parkinson's disease: a preliminary study. J Neurol Phys Ther. 2007 Dec;31(4):173-9. doi: 10.1097/NPT.0b013e31815ce78b. — View Citation
Marchant D, Sylvester JL, Earhart GM. Effects of a short duration, high dose contact improvisation dance workshop on Parkinson disease: a pilot study. Complement Ther Med. 2010 Oct;18(5):184-90. doi: 10.1016/j.ctim.2010.07.004. Epub 2010 Aug 21. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Berg Balance Scale (To assess change in balance) | The aim of the Berg Balance Scale is to assess functional balance (Marigold and Eng 2006). The measure consists of 14 items. Each item requires the participant to perform a functional balance task such as turning, stepping and reaching (Marigold and Eng 2006). A lower score is indicative of compromised balance performance. This measure is a valid and reliable measure and has being found to correlate with UPDRS scores and Hoeln and Yahr scale for staging of Parkinson's disease (Qutubuddin et al 2005). | This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. | No |
Secondary | Unified Parkinson's Disease Rating Scale 3 (UPDRS-3) (To assess changes in motor impairment) | UPDRS-3 is a motor subscale of the UPDRS. It is a measure of disease severity (Hackney et al 2007). The motor subscale examines various motor impairments which are associated with Parkinson's disease such as speech, tremor at rest, rigidity and gait (Heiberger et al 2011). Higher scores indicate more severe disease stage. This is a disease specific measure which is valid (Hackney et al 2007) and reliable with an excellent Intra-Class Correlation Co-efficient for test re-test reliability (Siderowf et al 2002), and intra-rater reliability (Metman et al 2004). | This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. | No |
Secondary | The Parkinson's Disease Questionnaire (PDQ-39) (To assess change in health related quality of life) | PDQ-39 will be used to assess health related quality of life (Marchant et al 2010). This questionnaire assesses the impact of Parkinson's disease in eight different areas including mobility, emotional well-being and communication. It has being found to be the most appropriate outcome measure to assess the impact of Parkinson's disease on health related quality of life as it is a disease specific test that is valid and reliable (Hackney et al 2009). Previous research has also found that this measure can detect changes in health related quality of life in response to physical activity interventions (Jenkinson et al 1997). | This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. | No |
Secondary | Six-Minute Walk Test (To assess change of functional exercise tolerance) | The six-minute walk test will be used to asses functional exercise tolerance (Falvo and Earhart 2009). This test requires participants to walk along a pre measured pathway for six minutes. This test is valid, reliable (Demers et al 2001; Schenkman et al 1997) and clinically applicable as it is simple to reproduce and reflects endurance needed for activities of daily living (Enright 2003). In previous studies, this test has detected changes in exercise tolerance in those with Parkinson's disease who completed a dance intervention (Hackney and Earhart 2009). | This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. | No |
Secondary | Zarit Care Giver Burden Interview (ZCBI)(To assess changes in caregiver burden) | ZCBI provides a multidimensional assessment of caregiver burden (Ankri et al 2005). The aim of this measure is to assess changes in caregiver burden over time (Hackney et al 2010). It consists of 22 items. Higher scores indicate greater caregiver burden (Hackney et al 2010). It is a valid and reliable measure for assessing the burden of caregivers involved in caring for those with Parkinson's disease (Martínez-Martín et al 2007). | This outcome will be assessed the week before the intervention begins and the week after the intervention period ends. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 |